Summary
Stryker Corporation (SYK) filed an 8-K on October 14, 2004, to report its third quarter and first nine months 2004 operating results. The key takeaway for investors is the company's presentation of adjusted net earnings, which excludes a purchased in-process research and development (R&D) charge. This adjusted figure is provided as a supplemental non-GAAP measure to offer a more consistent and comparable view of operational performance, aiding in the analysis of trends and future outlook. While the company emphasizes that this adjusted metric is not a replacement for its official GAAP financial results, it is presented to provide additional insight for investors. Management utilizes this adjusted net earnings figure for internal review and budgeting. Investors are encouraged to review the full financial statements and all public filings, and the press release containing the detailed reconciliation of GAAP to adjusted earnings is attached as an exhibit.
Key Highlights
- 1Stryker Corporation announced Q3 and first nine months 2004 operating results via an 8-K filing on October 14, 2004.
- 2The company is reporting adjusted net earnings that exclude a purchased in-process research and development (R&D) charge.
- 3The adjusted net earnings are presented as a supplemental non-GAAP financial measure.
- 4This non-GAAP measure is intended to provide a more consistent and comparable view of performance.
- 5Management uses the adjusted earnings for internal performance review and future trend analysis.
- 6Investors are advised to review both GAAP and non-GAAP figures, as well as the full financial statements.
- 7A reconciliation between reported net earnings (GAAP) and adjusted net earnings (non-GAAP) is available in the attached press release.